|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
116 |
0.170
|
|
|
regulation of cell death
|
GO:0010941 |
173 |
0.139
|
|
|
protein complex biogenesis
|
GO:0070271 |
201 |
0.123
|
|
|
homeostatic process
|
GO:0042592 |
199 |
0.115
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
62 |
0.114
|
|
|
epithelial cell differentiation
|
GO:0030855 |
322 |
0.114
|
|
|
compound eye morphogenesis
|
GO:0001745 |
249 |
0.088
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
368 |
0.087
|
|
|
columnar cuboidal epithelial cell development
|
GO:0002066 |
249 |
0.087
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
106 |
0.083
|
|
|
oxidation reduction process
|
GO:0055114 |
123 |
0.081
|
|
|
positive regulation of cell death
|
GO:0010942 |
69 |
0.076
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
153 |
0.076
|
|
|
cell proliferation
|
GO:0008283 |
299 |
0.076
|
|
|
regionalization
|
GO:0003002 |
416 |
0.072
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
73 |
0.071
|
|
|
regulation of erbb signaling pathway
|
GO:1901184 |
42 |
0.069
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
256 |
0.068
|
|
|
cell death
|
GO:0008219 |
279 |
0.067
|
|
|
regulation of cell development
|
GO:0060284 |
215 |
0.067
|
|
|
ovarian follicle cell development
|
GO:0030707 |
248 |
0.066
|
|
|
positive regulation of macromolecule metabolic process
|
GO:0010604 |
405 |
0.066
|
|
|
regulation of apoptotic process
|
GO:0042981 |
130 |
0.065
|
|
|
negative regulation of signaling
|
GO:0023057 |
219 |
0.061
|
|
|
positive regulation of response to stimulus
|
GO:0048584 |
323 |
0.060
|
|
|
vesicle mediated transport
|
GO:0016192 |
381 |
0.060
|
|
|
appendage morphogenesis
|
GO:0035107 |
397 |
0.060
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
119 |
0.057
|
|
|
response to oxidative stress
|
GO:0006979 |
86 |
0.055
|
|
|
single organism membrane fusion
|
GO:0044801 |
42 |
0.054
|
|
|
regulation of cell cycle
|
GO:0051726 |
291 |
0.054
|
|
|
negative regulation of response to stimulus
|
GO:0048585 |
258 |
0.053
|
|
|
intracellular transport
|
GO:0046907 |
228 |
0.050
|
|
|
programmed cell death
|
GO:0012501 |
257 |
0.049
|
|
|
regulation of cell cycle process
|
GO:0010564 |
181 |
0.049
|
|
|
organelle assembly
|
GO:0070925 |
198 |
0.049
|
|
|
epithelial cell development
|
GO:0002064 |
274 |
0.048
|
|
|
proteolysis
|
GO:0006508 |
192 |
0.048
|
|
|
atp metabolic process
|
GO:0046034 |
49 |
0.048
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
190 |
0.047
|
|
|
negative regulation of signal transduction
|
GO:0009968 |
206 |
0.047
|
|
|
rna processing
|
GO:0006396 |
147 |
0.046
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
4 |
0.045
|
|
|
negative regulation of nucleic acid templated transcription
|
GO:1903507 |
240 |
0.045
|
|
|
rna splicing
|
GO:0008380 |
83 |
0.045
|
|
|
protein modification process
|
GO:0036211 |
438 |
0.045
|
|
|
eye development
|
GO:0001654 |
323 |
0.043
|
|
|
membrane fusion
|
GO:0061025 |
42 |
0.042
|
|
|
eye morphogenesis
|
GO:0048592 |
260 |
0.042
|
|
|
axonogenesis
|
GO:0007409 |
290 |
0.042
|
|
|
endocytosis
|
GO:0006897 |
310 |
0.042
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
16 |
0.041
|
|
|
negative regulation of cell communication
|
GO:0010648 |
223 |
0.041
|
|
|
positive regulation of cell communication
|
GO:0010647 |
250 |
0.040
|
|
|
skin development
|
GO:0043588 |
65 |
0.040
|
|
|
imaginal disc derived appendage development
|
GO:0048737 |
399 |
0.038
|
|
|
erbb signaling pathway
|
GO:0038127 |
58 |
0.038
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
127 |
0.038
|
|
|
segmentation
|
GO:0035282 |
207 |
0.038
|
|
|
cell division
|
GO:0051301 |
248 |
0.037
|
|
|
endosomal transport
|
GO:0016197 |
44 |
0.037
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
52 |
0.037
|
|
|
positive regulation of gene expression
|
GO:0010628 |
290 |
0.036
|
|
|
negative regulation of transcription dna templated
|
GO:0045892 |
237 |
0.036
|
|
|
positive regulation of nucleobase containing compound metabolic process
|
GO:0045935 |
332 |
0.036
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
354 |
0.035
|
|
|
regulation of catalytic activity
|
GO:0050790 |
185 |
0.035
|
|
|
membrane organization
|
GO:0061024 |
112 |
0.034
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
127 |
0.034
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
26 |
0.034
|
|
|
appendage development
|
GO:0048736 |
401 |
0.034
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
179 |
0.034
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
127 |
0.033
|
|
|
regulation of cell differentiation
|
GO:0045595 |
302 |
0.033
|
|
|
response to radiation
|
GO:0009314 |
155 |
0.032
|
|
|
epidermal growth factor receptor signaling pathway
|
GO:0007173 |
58 |
0.032
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
130 |
0.032
|
|
|
regulation of transcription from rna polymerase ii promoter
|
GO:0006357 |
378 |
0.031
|
|
|
negative regulation of cell death
|
GO:0060548 |
81 |
0.030
|
|
|
response to external biotic stimulus
|
GO:0043207 |
293 |
0.030
|
|
|
defense response to other organism
|
GO:0098542 |
225 |
0.030
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
68 |
0.030
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
25 |
0.029
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
93 |
0.029
|
|
|
chromosome segregation
|
GO:0007059 |
157 |
0.029
|
|
|
neuron projection guidance
|
GO:0097485 |
241 |
0.028
|
|
|
cell motility
|
GO:0048870 |
251 |
0.028
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
162 |
0.028
|
|
|
positive regulation of transcription dna templated
|
GO:0045893 |
266 |
0.027
|
|
|
negative regulation of developmental process
|
GO:0051093 |
201 |
0.027
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
112 |
0.027
|
|
|
regulation of response to stress
|
GO:0080134 |
200 |
0.027
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
50 |
0.027
|
|
|
tissue morphogenesis
|
GO:0048729 |
297 |
0.026
|
|
|
macromolecular complex assembly
|
GO:0065003 |
256 |
0.026
|
|
|
regulation of cellular component size
|
GO:0032535 |
98 |
0.026
|
|
|
developmental maturation
|
GO:0021700 |
172 |
0.026
|
|
|
positive regulation of signal transduction
|
GO:0009967 |
223 |
0.026
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
52 |
0.026
|
|
|
protein ubiquitination
|
GO:0016567 |
70 |
0.026
|
|
|
apoptotic process
|
GO:0006915 |
159 |
0.026
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
50 |
0.026
|
|
|
dna metabolic process
|
GO:0006259 |
227 |
0.026
|
|
|
organelle fusion
|
GO:0048284 |
46 |
0.026
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
17 |
0.026
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
61 |
0.025
|
|
|
regulation of growth
|
GO:0040008 |
233 |
0.025
|
|
|
intracellular signal transduction
|
GO:0035556 |
300 |
0.025
|
|
|
oocyte axis specification
|
GO:0007309 |
108 |
0.025
|
|
|
phagocytosis
|
GO:0006909 |
215 |
0.025
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
318 |
0.025
|
|
|
compound eye development
|
GO:0048749 |
307 |
0.025
|
|
|
single organism membrane organization
|
GO:0044802 |
93 |
0.024
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
167 |
0.024
|
|
|
oocyte differentiation
|
GO:0009994 |
145 |
0.024
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
155 |
0.024
|
|
|
wing disc morphogenesis
|
GO:0007472 |
344 |
0.024
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
23 |
0.024
|
|
|
chemotaxis
|
GO:0006935 |
249 |
0.024
|
|
|
regulation of molecular function
|
GO:0065009 |
217 |
0.023
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
97 |
0.023
|
|
|
regulation of phosphate metabolic process
|
GO:0019220 |
210 |
0.023
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.023
|
|
|
negative regulation of macromolecule biosynthetic process
|
GO:0010558 |
270 |
0.023
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
151 |
0.023
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
73 |
0.023
|
|
|
regulation of nervous system development
|
GO:0051960 |
248 |
0.023
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
276 |
0.023
|
|
|
positive regulation of transcription from rna polymerase ii promoter
|
GO:0045944 |
204 |
0.023
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
120 |
0.022
|
|
|
positive regulation of protein metabolic process
|
GO:0051247 |
128 |
0.022
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
145 |
0.022
|
|
|
regulation of cellular protein metabolic process
|
GO:0032268 |
243 |
0.022
|
|
|
cytoplasmic transport
|
GO:0016482 |
130 |
0.021
|
|
|
meiotic nuclear division
|
GO:0007126 |
151 |
0.021
|
|
|
mrna processing
|
GO:0006397 |
104 |
0.021
|
|
|
cell maturation
|
GO:0048469 |
144 |
0.021
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
112 |
0.021
|
|
|
cellular response to radiation
|
GO:0071478 |
52 |
0.021
|
|
|
neuron remodeling
|
GO:0016322 |
29 |
0.021
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
260 |
0.021
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
24 |
0.020
|
|
|
cellular protein modification process
|
GO:0006464 |
438 |
0.020
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
414 |
0.020
|
|
|
mrna metabolic process
|
GO:0016071 |
124 |
0.020
|
|
|
establishment of localization in cell
|
GO:0051649 |
402 |
0.020
|
|
|
regulation of programmed cell death
|
GO:0043067 |
152 |
0.020
|
|
|
positive regulation of rna metabolic process
|
GO:0051254 |
271 |
0.020
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
127 |
0.020
|
|
|
imaginal disc derived appendage morphogenesis
|
GO:0035114 |
395 |
0.020
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
174 |
0.020
|
|
|
cell cycle phase transition
|
GO:0044770 |
140 |
0.019
|
|
|
regulation of intracellular signal transduction
|
GO:1902531 |
236 |
0.019
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
79 |
0.019
|
|
|
epidermis development
|
GO:0008544 |
65 |
0.019
|
|
|
nuclear division
|
GO:0000280 |
332 |
0.019
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
136 |
0.019
|
|
|
growth
|
GO:0040007 |
359 |
0.018
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
118 |
0.018
|
|
|
phosphorylation
|
GO:0016310 |
294 |
0.018
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
130 |
0.018
|
|
|
positive regulation of signaling
|
GO:0023056 |
243 |
0.018
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
119 |
0.018
|
|
|
regulation of proteolysis
|
GO:0030162 |
87 |
0.018
|
|
|
regulation of cell proliferation
|
GO:0042127 |
163 |
0.018
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
165 |
0.018
|
|
|
protein complex assembly
|
GO:0006461 |
200 |
0.017
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
145 |
0.017
|
|
|
male gamete generation
|
GO:0048232 |
201 |
0.017
|
|
|
cellular protein complex assembly
|
GO:0043623 |
71 |
0.017
|
|
|
regulation of phosphorus metabolic process
|
GO:0051174 |
210 |
0.017
|
|
|
protein localization
|
GO:0008104 |
284 |
0.017
|
|
|
imaginal disc derived wing morphogenesis
|
GO:0007476 |
337 |
0.017
|
|
|
regulation of organelle organization
|
GO:0033043 |
196 |
0.017
|
|
|
single organism intracellular transport
|
GO:1902582 |
207 |
0.016
|
|
|
response to oxygen containing compound
|
GO:1901700 |
200 |
0.016
|
|
|
negative regulation of nucleobase containing compound metabolic process
|
GO:0045934 |
261 |
0.016
|
|
|
response to extracellular stimulus
|
GO:0009991 |
116 |
0.016
|
|
|
regulation of protein metabolic process
|
GO:0051246 |
256 |
0.016
|
|
|
response to abiotic stimulus
|
GO:0009628 |
341 |
0.016
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
265 |
0.016
|
|
|
positive regulation of rna biosynthetic process
|
GO:1902680 |
266 |
0.016
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
72 |
0.016
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
163 |
0.016
|
|
|
dendrite morphogenesis
|
GO:0048813 |
199 |
0.016
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
145 |
0.016
|
|
|
positive regulation of nucleic acid templated transcription
|
GO:1903508 |
266 |
0.016
|
|
|
regulation of transport
|
GO:0051049 |
181 |
0.016
|
|
|
embryonic axis specification
|
GO:0000578 |
107 |
0.016
|
|
|
regulation of immune response
|
GO:0050776 |
118 |
0.016
|
|
|
regulation of defense response
|
GO:0031347 |
102 |
0.016
|
|
|
response to light stimulus
|
GO:0009416 |
124 |
0.016
|
|
|
organophosphate metabolic process
|
GO:0019637 |
195 |
0.015
|
|
|
cellular homeostasis
|
GO:0019725 |
80 |
0.015
|
|
|
axon guidance
|
GO:0007411 |
233 |
0.015
|
|
|
germarium derived egg chamber formation
|
GO:0007293 |
101 |
0.015
|
|
|
organelle fission
|
GO:0048285 |
340 |
0.015
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
75 |
0.015
|
|
|
instar larval development
|
GO:0002168 |
55 |
0.015
|
|
|
sex differentiation
|
GO:0007548 |
81 |
0.015
|
|
|
response to inorganic substance
|
GO:0010035 |
44 |
0.015
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
38 |
0.015
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
47 |
0.015
|
|
|
reproductive structure development
|
GO:0048608 |
74 |
0.015
|
|
|
negative regulation of rna metabolic process
|
GO:0051253 |
251 |
0.014
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
29 |
0.014
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
170 |
0.014
|
|
|
neuron maturation
|
GO:0042551 |
31 |
0.014
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
145 |
0.014
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
69 |
0.014
|
|
|
regulation of multi organism process
|
GO:0043900 |
131 |
0.014
|
|
|
carbohydrate derivative metabolic process
|
GO:1901135 |
217 |
0.014
|
|
|
protein maturation
|
GO:0051604 |
71 |
0.014
|
|
|
response to ionizing radiation
|
GO:0010212 |
32 |
0.014
|
|
|
stem cell division
|
GO:0017145 |
69 |
0.014
|
|
|
wnt signaling pathway
|
GO:0016055 |
98 |
0.013
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
109 |
0.013
|
|
|
neuromuscular junction development
|
GO:0007528 |
149 |
0.013
|
|
|
cell growth
|
GO:0016049 |
108 |
0.013
|
|
|
positive regulation of biosynthetic process
|
GO:0009891 |
316 |
0.013
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
74 |
0.013
|
|
|
nucleoside catabolic process
|
GO:0009164 |
112 |
0.013
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
25 |
0.013
|
|
|
organophosphate catabolic process
|
GO:0046434 |
112 |
0.013
|
|
|
cell cycle arrest
|
GO:0007050 |
4 |
0.013
|
|
|
negative regulation of erbb signaling pathway
|
GO:1901185 |
29 |
0.013
|
|
|
organelle localization
|
GO:0051640 |
148 |
0.013
|
|
|
body morphogenesis
|
GO:0010171 |
2 |
0.013
|
|
|
positive regulation of cellular biosynthetic process
|
GO:0031328 |
316 |
0.013
|
|
|
cellular catabolic process
|
GO:0044248 |
372 |
0.013
|
|
|
larval development
|
GO:0002164 |
104 |
0.013
|
|
|
regulation of innate immune response
|
GO:0045088 |
71 |
0.013
|
|
|
positive regulation of molecular function
|
GO:0044093 |
136 |
0.013
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
138 |
0.013
|
|
|
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
|
GO:0070059 |
4 |
0.012
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
51 |
0.012
|
|
|
oocyte construction
|
GO:0007308 |
112 |
0.012
|
|
|
nucleotide catabolic process
|
GO:0009166 |
109 |
0.012
|
|
|
regulation of peptidase activity
|
GO:0052547 |
39 |
0.012
|
|
|
transmembrane transport
|
GO:0055085 |
139 |
0.012
|
|
|
synaptic vesicle localization
|
GO:0097479 |
53 |
0.012
|
|
|
female meiotic division
|
GO:0007143 |
70 |
0.012
|
|
|
anterior posterior axis specification
|
GO:0009948 |
109 |
0.012
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
50 |
0.012
|
|
|
immune system process
|
GO:0002376 |
347 |
0.012
|
|
|
developmental growth
|
GO:0048589 |
280 |
0.012
|
|
|
centrosome organization
|
GO:0051297 |
163 |
0.012
|
|
|
gonad development
|
GO:0008406 |
50 |
0.012
|
|
|
extracellular matrix assembly
|
GO:0085029 |
13 |
0.012
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
145 |
0.012
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
28 |
0.012
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
36 |
0.012
|
|
|
negative regulation of cellular macromolecule biosynthetic process
|
GO:2000113 |
267 |
0.012
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
88 |
0.011
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
143 |
0.011
|
|
|
anterior posterior pattern specification
|
GO:0009952 |
136 |
0.011
|
|
|
g2 dna damage checkpoint
|
GO:0031572 |
69 |
0.011
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
119 |
0.011
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
201 |
0.011
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
16 |
0.011
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
73 |
0.011
|
|
|
cellular respiration
|
GO:0045333 |
26 |
0.011
|
|
|
ion transmembrane transport
|
GO:0034220 |
122 |
0.011
|
|
|
imaginal disc derived leg segmentation
|
GO:0036011 |
26 |
0.011
|
|
|
cytoplasm organization
|
GO:0007028 |
64 |
0.011
|
|
|
axon development
|
GO:0061564 |
297 |
0.011
|
|
|
centrosome duplication
|
GO:0051298 |
121 |
0.011
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
32 |
0.011
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
39 |
0.011
|
|
|
response to other organism
|
GO:0051707 |
293 |
0.011
|
|
|
organic substance catabolic process
|
GO:1901575 |
308 |
0.011
|
|
|
stem cell proliferation
|
GO:0072089 |
88 |
0.011
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
38 |
0.011
|
|
|
vesicle organization
|
GO:0016050 |
44 |
0.011
|
|
|
asymmetric protein localization
|
GO:0008105 |
33 |
0.010
|
|
|
positive regulation of macromolecule biosynthetic process
|
GO:0010557 |
283 |
0.010
|
|
|
positive regulation of catalytic activity
|
GO:0043085 |
118 |
0.010
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
103 |
0.010
|
|
|
post embryonic appendage morphogenesis
|
GO:0035120 |
385 |
0.010
|
|
|
actin filament based process
|
GO:0030029 |
220 |
0.010
|
|
|
negative regulation of epidermal growth factor receptor signaling pathway
|
GO:0042059 |
29 |
0.010
|
|
|
protein phosphorylation
|
GO:0006468 |
169 |
0.010
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
27 |
0.010
|
|